| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.055 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |